EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity

Haris Vikis; Mitsuo Sato; Michael James; Daolong Wang; Yian Wang; Min Wang; Dongmei Jia; Yan Liu; Joan E. Bailey-Wilson; Christopher I. Amos; Susan M. Pinney; Gloria M. Petersen; Mariza De Andrade; Ping Yang; Jonathan S. Wiest; Pamela R. Fain; Ann G. Schwartz; Adi Gazdar; Colette Gaba; Henry Rothschild; Diptasri Mandal; Elena Kupert; Daniela Seminara; Avinash Viswanathan; Ramaswamy Govindan; John Minna; Marshall W. Anderson; Ming You

doi:10.1158/0008-5472.CAN-07-0217

EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity

Haris Vikis, Mitsuo Sato, Michael James, Daolong Wang, Yian Wang, Min Wang, Dongmei Jia, Yan Liu, Joan E. Bailey-Wilson, Christopher I. Amos, Susan M. Pinney, Gloria M. Petersen, Mariza De Andrade, Ping Yang, Jonathan S. Wiest, Pamela R. Fain, Ann G. Schwartz, Adi Gazdar, Colette Gaba, Henry RothschildDiptasri Mandal, Elena Kupert, Daniela Seminara, Avinash Viswanathan, Ramaswamy Govindan, John Minna, Marshall W. Anderson, Ming You

Research output: Contribution to journal › Article › peer-review

88 Scopus citations

Abstract

The use of tyrosine kinase inhibitors (TKI) has yielded great success in treatment of lung adenocarcinomas. However, patients who develop resistance to TKI treatment often acquire a somatic resistance mutation (T790M) located in the catalytic cleft of the epidermal growth factor receptor (EGFR) enzyme. Recently, a report describing EGFR-T790M as a germ-line mutation suggested that this mutation may be associated with inherited susceptibility to lung cancer. Contrary to previous reports, our analysis indicates that the T790M mutation confers increased Y992 and Y1068 phosphorylation levels. In a human bronchial epithelial cell line, overexpression of EGFR-T790M displayed a growth advantage over wild-type (WT) EGFR. We also screened 237 lung cancer family probands, in addition to 45 bronchoalveolar tumors, and found that none of them contained the EGFR-T790M mutation. Our observations show that EGFR-T790M provides a proliferative advantage with respect to WT EGFR and suggest that the enhanced kinase activity of this mutant is the basis for rare cases of inherited susceptibility to lung cancer.

Original language	English (US)
Pages (from-to)	4665-4670
Number of pages	6
Journal	Cancer research
Volume	67
Issue number	10
DOIs	https://doi.org/10.1158/0008-5472.CAN-07-0217
State	Published - May 15 2007

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/0008-5472.CAN-07-0217

Cite this

Vikis, H., Sato, M., James, M., Wang, D., Wang, Y., Wang, M., Jia, D., Liu, Y., Bailey-Wilson, J. E., Amos, C. I., Pinney, S. M., Petersen, G. M., De Andrade, M., Yang, P., Wiest, J. S., Fain, P. R., Schwartz, A. G., Gazdar, A., Gaba, C., ... You, M. (2007). EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. Cancer research, 67(10), 4665-4670. https://doi.org/10.1158/0008-5472.CAN-07-0217

Vikis, H, Sato, M, James, M, Wang, D, Wang, Y, Wang, M, Jia, D, Liu, Y, Bailey-Wilson, JE, Amos, CI, Pinney, SM, Petersen, GM, De Andrade, M, Yang, P, Wiest, JS, Fain, PR, Schwartz, AG, Gazdar, A, Gaba, C, Rothschild, H, Mandal, D, Kupert, E, Seminara, D, Viswanathan, A, Govindan, R, Minna, J, Anderson, MW & You, M 2007, 'EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity', Cancer research, vol. 67, no. 10, pp. 4665-4670. https://doi.org/10.1158/0008-5472.CAN-07-0217

@article{1f723d5ee86a43ea80808817933ecad6,

title = "EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity",

abstract = "The use of tyrosine kinase inhibitors (TKI) has yielded great success in treatment of lung adenocarcinomas. However, patients who develop resistance to TKI treatment often acquire a somatic resistance mutation (T790M) located in the catalytic cleft of the epidermal growth factor receptor (EGFR) enzyme. Recently, a report describing EGFR-T790M as a germ-line mutation suggested that this mutation may be associated with inherited susceptibility to lung cancer. Contrary to previous reports, our analysis indicates that the T790M mutation confers increased Y992 and Y1068 phosphorylation levels. In a human bronchial epithelial cell line, overexpression of EGFR-T790M displayed a growth advantage over wild-type (WT) EGFR. We also screened 237 lung cancer family probands, in addition to 45 bronchoalveolar tumors, and found that none of them contained the EGFR-T790M mutation. Our observations show that EGFR-T790M provides a proliferative advantage with respect to WT EGFR and suggest that the enhanced kinase activity of this mutant is the basis for rare cases of inherited susceptibility to lung cancer.",

author = "Haris Vikis and Mitsuo Sato and Michael James and Daolong Wang and Yian Wang and Min Wang and Dongmei Jia and Yan Liu and Bailey-Wilson, {Joan E.} and Amos, {Christopher I.} and Pinney, {Susan M.} and Petersen, {Gloria M.} and {De Andrade}, Mariza and Ping Yang and Wiest, {Jonathan S.} and Fain, {Pamela R.} and Schwartz, {Ann G.} and Adi Gazdar and Colette Gaba and Henry Rothschild and Diptasri Mandal and Elena Kupert and Daniela Seminara and Avinash Viswanathan and Ramaswamy Govindan and John Minna and Anderson, {Marshall W.} and Ming You",

year = "2007",

month = may,

day = "15",

doi = "10.1158/0008-5472.CAN-07-0217",

language = "English (US)",

volume = "67",

pages = "4665--4670",

journal = "Cancer research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "10",

}

TY - JOUR

T1 - EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity

AU - Vikis, Haris

AU - Sato, Mitsuo

AU - James, Michael

AU - Wang, Daolong

AU - Wang, Yian

AU - Wang, Min

AU - Jia, Dongmei

AU - Liu, Yan

AU - Bailey-Wilson, Joan E.

AU - Amos, Christopher I.

AU - Pinney, Susan M.

AU - Petersen, Gloria M.

AU - De Andrade, Mariza

AU - Yang, Ping

AU - Wiest, Jonathan S.

AU - Fain, Pamela R.

AU - Schwartz, Ann G.

AU - Gazdar, Adi

AU - Gaba, Colette

AU - Rothschild, Henry

AU - Mandal, Diptasri

AU - Kupert, Elena

AU - Seminara, Daniela

AU - Viswanathan, Avinash

AU - Govindan, Ramaswamy

AU - Minna, John

AU - Anderson, Marshall W.

AU - You, Ming

PY - 2007/5/15

Y1 - 2007/5/15

N2 - The use of tyrosine kinase inhibitors (TKI) has yielded great success in treatment of lung adenocarcinomas. However, patients who develop resistance to TKI treatment often acquire a somatic resistance mutation (T790M) located in the catalytic cleft of the epidermal growth factor receptor (EGFR) enzyme. Recently, a report describing EGFR-T790M as a germ-line mutation suggested that this mutation may be associated with inherited susceptibility to lung cancer. Contrary to previous reports, our analysis indicates that the T790M mutation confers increased Y992 and Y1068 phosphorylation levels. In a human bronchial epithelial cell line, overexpression of EGFR-T790M displayed a growth advantage over wild-type (WT) EGFR. We also screened 237 lung cancer family probands, in addition to 45 bronchoalveolar tumors, and found that none of them contained the EGFR-T790M mutation. Our observations show that EGFR-T790M provides a proliferative advantage with respect to WT EGFR and suggest that the enhanced kinase activity of this mutant is the basis for rare cases of inherited susceptibility to lung cancer.

AB - The use of tyrosine kinase inhibitors (TKI) has yielded great success in treatment of lung adenocarcinomas. However, patients who develop resistance to TKI treatment often acquire a somatic resistance mutation (T790M) located in the catalytic cleft of the epidermal growth factor receptor (EGFR) enzyme. Recently, a report describing EGFR-T790M as a germ-line mutation suggested that this mutation may be associated with inherited susceptibility to lung cancer. Contrary to previous reports, our analysis indicates that the T790M mutation confers increased Y992 and Y1068 phosphorylation levels. In a human bronchial epithelial cell line, overexpression of EGFR-T790M displayed a growth advantage over wild-type (WT) EGFR. We also screened 237 lung cancer family probands, in addition to 45 bronchoalveolar tumors, and found that none of them contained the EGFR-T790M mutation. Our observations show that EGFR-T790M provides a proliferative advantage with respect to WT EGFR and suggest that the enhanced kinase activity of this mutant is the basis for rare cases of inherited susceptibility to lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=34250329445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250329445&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-07-0217

DO - 10.1158/0008-5472.CAN-07-0217

M3 - Article

C2 - 17510392

AN - SCOPUS:34250329445

SN - 0008-5472

VL - 67

SP - 4665

EP - 4670

JO - Cancer research

JF - Cancer research

IS - 10

ER -

EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this